{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:18:57Z","timestamp":1793755137877,"version":"4.6.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T00:00:00Z","timestamp":1744502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010983","name":"Health Research Foundation of Central Denmark Region","doi-asserted-by":"publisher","award":["A3192"],"award-info":[{"award-number":["A3192"]}],"id":[{"id":"10.13039\/501100010983","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007420","name":"Danish Medical Association","doi-asserted-by":"publisher","award":["2019-3780\/41"],"award-info":[{"award-number":["2019-3780\/41"]}],"id":[{"id":"10.13039\/501100007420","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF170C0029064"],"award-info":[{"award-number":["NNF170C0029064"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jdiacomp.2025.109039","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T03:24:22Z","timestamp":1744255462000},"page":"109039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Semaglutide, central retinal thickness and continuous glucose monitoring in persons with type 2 diabetes: A post-hoc analysis from a randomised trial"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8275-1278","authenticated-orcid":false,"given":"S\u00f8ren","family":"Gullaksen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2875-435X","authenticated-orcid":false,"given":"Liv","family":"Vernstr\u00f8m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen Skovgaard","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0213-5550","authenticated-orcid":false,"given":"Kristian L\u00f8kke","family":"Funck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0409-2534","authenticated-orcid":false,"given":"Toke","family":"Bek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6468-2715","authenticated-orcid":false,"given":"Per L\u00f8gstrup","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1782-1596","authenticated-orcid":false,"given":"Esben","family":"Laugesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2025.109039_bb0005","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0010","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJMra1909637","article-title":"Evaluation and care of patients with diabetic retinopathy","volume":"382","author":"Jampol","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0015","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0020","article-title":"Diabetic retinopathy: pathophysiology and treatments","volume":"19","author":"Wang","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2337\/dc16-2641","article-title":"Diabetic retinopathy: a position statement by the American Diabetes Association","volume":"40","author":"Solomon","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13300-021-01190-z","article-title":"Early worsening of retinopathy in type 1 and type 2 diabetes after rapid improvement in glycaemic control: a systematic review","volume":"13","author":"Akil","year":"2022","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0035","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0040","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0045","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","article-title":"Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes","volume":"377","author":"Holman","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0050","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0055","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","article-title":"Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony outcomes): a double-blind, randomised placebo-controlled trial","volume":"392","author":"Hernandez","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0060","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa2108269","article-title":"Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes","volume":"385","author":"Gerstein","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0065","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.2337\/db16-1364","article-title":"GLP-1R as a target for the treatment of diabetic retinopathy: friend or foe?","volume":"66","author":"Sim\u00f3","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0070","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/dom.13172","article-title":"Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy","volume":"20","author":"Vilsboll","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0075","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2337\/dc20-1815","article-title":"HbA1c change and diabetic retinopathy during GLP-1 receptor agonist cardiovascular outcome trials: a meta-analysis and meta-regression","volume":"44","author":"Bethel","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0080","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/dom.14197","article-title":"Sodium-glucose co-transporter-2 inhibition and ocular outcomes in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"23","author":"Li","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0090","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00125-024-06107-6","article-title":"Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis","volume":"67","author":"Jancev","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0095","doi-asserted-by":"crossref","DOI":"10.2337\/db23-941-P","article-title":"941-P: improved glycemic control with real-time CGM in adults with type 2 diabetes not treated with insulin","volume":"72","author":"Jepson","year":"2023","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2023.108472","article-title":"Effects of semaglutide and empagliflozin on oxygenation, vascular autoregulation, and central thickness of the retina in people with type 2 diabetes: a prespecified secondary analysis of a randomised clinical trial","author":"Gullaksen","year":"2023","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0105","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00125-023-05876-w","article-title":"Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial","volume":"66","author":"Gullaksen","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0110","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1111\/dom.15464","article-title":"Separate and combined effects of empagliflozin and semaglutide on vascular function: a 32-week randomized trial","volume":"26","author":"Vernstr\u00f8m","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0115","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/bjophthalmol-2018-312764","article-title":"Retinal oxygen saturation is an independent risk factor for the severity of diabetic retinopathy","volume":"103","author":"Bek","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0120","series-title":"Applied Longitudinal Analysis","author":"Fitzmaurice","year":"2011"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0125","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/dom.13484","article-title":"Glucagon-like peptide-1 receptor agonists and microvascular outcomes in type 2 diabetes: a systematic review and meta-analysis","volume":"21","author":"Avgerinos","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0130","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.2337\/dc06-0293","article-title":"The effect of glucose variability on the risk of microvascular complications in type 1 diabetes","volume":"29","author":"Kilpatrick","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0135","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.2337\/dc09-0109","article-title":"Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes","volume":"32","author":"Kilpatrick","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0140","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00125-024-06132-5","article-title":"Risk of diabetic retinopathy and diabetic macular oedema with sodium\u2013glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database","volume":"67","author":"Eleftheriadou","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0145","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/eye.2012.53","article-title":"Observational study of subclinical diabetic macular edema","volume":"26","author":"Bressler","year":"2012","journal-title":"Eye"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0150","doi-asserted-by":"crossref","first-page":"e1549","DOI":"10.1210\/clinem\/dgz069","article-title":"Glucagon-like peptide 1 receptor agonists, diabetic retinopathy and angiogenesis: the AngioSafe type 2 diabetes study","volume":"105","author":"Gaborit","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0155","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/dom.13232","article-title":"Comparisons of diabetic retinopathy events associated with glucose-lowering drugs in patients with type 2 diabetes mellitus: a network meta-analysis","volume":"20","author":"Tang","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0160","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-023-02753-6","article-title":"Glucagon-like peptide-1 receptor agonists and diabetic retinopathy: nationwide cohort and Mendelian randomization studies","volume":"21","author":"Zheng","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0170","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.2337\/dc18-1131","article-title":"Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes","volume":"41","author":"Lu","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1383345","article-title":"Glycemic profile variability as an independent predictor of diabetic retinopathy in patients with type 2 diabetes: a prospective cohort study","volume":"15","author":"Dehghani Firouzabadi","year":"2024","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0190","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/jamaophthalmol.2024.2296","article-title":"Risk of Nonarteritic anterior ischemic optic neuropathy in patients prescribed semaglutide","volume":"142","author":"Hathaway","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0195","author":"Denmark UoS"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0200","article-title":"Association between semaglutide and non-arteritic anterior ischemic optic neuropathy: a multinational population-based real-world study","author":"Chou","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2025.109039_bb0205","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3109\/02713683.2013.781191","article-title":"Repeatability and reproducibility of retinal thickness measurements in diabetic patients with spectral domain optical coherence tomography","volume":"38","author":"Fiore","year":"2013","journal-title":"Curr Eye Res"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872725000923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872725000923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:05:10Z","timestamp":1762362310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872725000923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1056872725000923"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109039","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Semaglutide, central retinal thickness and continuous glucose monitoring in persons with type 2 diabetes: A post-hoc analysis from a randomised trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"109039"}}